For example, a clinical trial involving semaglutide reported that participants with a baseline body mass index (BMI) over 35 kg/m lost an average of 15% of their body weight after 68 weeks, while those with lower baseline weights lost less in relative terms
Injection Technique Route: Subcutaneous (into the fat layer beneath the skin) Syringe: Insulin syringe, 29 to 31 gauge, 0.5 mL or 1 mL Sites: Abdomen (2 inches from the navel), outer thigh, or upper arm Pinch a fold of skin at the injection site
Since semaglutide is injected under the skin rather than taken by mouth, meals do not interfere with absorption or efficacy
Patients with pre-existing orthostatic hypotension or autonomic dysfunction face higher risk
Discuss this honestly with your doctor
This gentler transition gives you time to reinforce eating habits, test your ability to self-regulate portions, and identify which foods and meal patterns support satiety without medication